Period | Date | Adjusted Actuals EPS | GAAP EPS |
---|---|---|---|
Q3 2022 | 2022-10-24 | Future report Set alerts | |
Q2 2022 | 2022-08-09 | 1.35 | 1.35 |
Q1 2022 | 2022-05-03 | 0.93 | 0.93 |
Q4 2021 | 2022-02-15 | 1.21 | 1.21 |
Q3 2021 | 2021-10-26 | 0.94 | 0.94 |
Q2 2021 | 2021-07-27 | 0.94 | 0.94 |
Q1 2021 | 2021-04-26 | 0.90 | 0.90 |
Q4 2020 | 2021-02-23 | 0.98 | 0.98 |
Q3 2020 | 2020-10-27 | 0.80 | 0.80 |
Q2 2020 | 2020-07-28 | 0.85 | 0.85 |
2016-06-01 | Downgrade | Raymond James | Strong-Buy to Outperform | |
2016-06-01 | Downgrade | Raymond James Financial Inc. | Strong-Buy to Outperform | |
2016-05-05 | Boost Price Target | Wedbush | Outperform | $51.00 to $57.00 |
2016-05-05 | Upgrade | Piper Jaffray | Neutral to Overweight | $43.00 to $52.00 |
2016-05-05 | Boost Price Target | Roth Capital | Buy | $40.00 to $50.00 |
2016-05-05 | Upgrade | Piper Jaffray Cos. | Neutral to Overweight | $43.00 to $52.00 |
2016-03-01 | Reiterated Rating | BTIG Research | Neutral | |
2016-02-26 | Lower Price Target | Raymond James | Outperform | $46.00 to $44.00 |
2016-02-24 | Reiterated Rating | Roth Capital | Buy | |
2016-02-24 | Reiterated Rating | Wedbush | Outperform | $51.00 |
2016-01-06 | Downgrade | Raymond James | Strong-Buy to Outperform | $50.00 to $46.00 |
2015-12-16 | Reiterated Rating | Roth Capital | Buy | |
2015-11-19 | Reiterated Rating | Wedbush | Outperform | $51.00 |
2015-11-08 | Reiterated Rating | BTIG Research | Neutral | |
2015-11-06 | Boost Price Target | Wedbush | Outperform | $46.00 to $51.00 |
2015-10-20 | Reiterated Rating | Piper Jaffray | Hold | $34.00 to $43.00 |
2015-10-02 | Reiterated Rating | Roth Capital | Buy | $46.00 |
2015-08-05 | Reiterated Rating | BTIG Research | Hold | |
2015-08-05 | Boost Price Target | Roth Capital | Buy | $39.00 to $46.00 |
2015-07-21 | Reiterated Rating | Roth Capital | Buy | |
2015-07-16 | Downgrade | BTIG Research | Buy to Neutral | |
2015-06-22 | Boost Price Target | Wedbush | Outperform | $40.00 to $44.00 |
2015-06-12 | Upgrade | Raymond James | Market Perform to Strong-Buy | $46.00 |
2015-05-08 | Reiterated Rating | BTIG Research | Buy | $38.00 |
2015-05-07 | Boost Price Target | Roth Capital | Buy | $29.00 to $38.00 |
2015-02-18 | Set Price Target | Roth Capital | Buy | $29.00 |
2015-02-18 | Set Price Target | BTIG Research | Buy | $32.00 |
2015-01-09 | Reiterated Rating | Off Wall Street | Sell | |
2015-01-07 | Set Price Target | Wedbush | Buy | $31.00 |
2014-08-11 | Reiterated Rating | Citigroup Inc. | Neutral | $29.00 to $27.00 |
2014-08-08 | Lower Price Target | BMO Capital Markets | $26.00 to $24.00 | |
2014-08-08 | Lower Price Target | Roth Capital | $32.00 to $28.00 | |
2014-08-08 | Downgrade | Piper Jaffray | Overweight to Neutral | |
2014-07-08 | Initiated Coverage | BTIG Research | Buy | $32.00 |
2014-05-02 | Reiterated Rating | Citigroup Inc. | Hold | $29.00 |
2013-10-31 | Boost Price Target | Roth Capital | Buy | $29.00 to $32.00 |
2013-10-31 | Boost Price Target | Feltl & Co. | Hold | $22.00 to $26.00 |
2013-10-31 | Reiterated Rating | BMO Capital Markets | Market Perform | $22.00 to $24.00 |
2012-02-15 | Reiterated | Brean Murray | Buy | $24 to $26 |
2012-01-13 | Reiterated | Brean Murray | Buy | $27 to $24 |
2011-09-14 | Initiated | Collins Stewart | Buy | $28 |
2011-08-15 | Initiated | Feltl & Co. | Hold | |
2011-08-10 | Reiterated | Brean Murray | Buy | $33 to $29 |
2011-06-15 | Initiated | Brean Murray | Buy | $33 |
2011-04-04 | Downgrade | Barrington Research | Outperform to Mkt Perform | |
2010-05-06 | Upgrade | Boenning & Scattergood | Neutral to Outperform | $29 |
2009-12-04 | Initiated | Barrington Research | Outperform | $33 |
2009-06-03 | Initiated | William Blair | Mkt Perform | |
2009-03-23 | Reiterated | Lazard Capital Mkts | Buy | $45 to $43 |
2008-04-28 | Upgrade | Citigroup | Hold to Buy |
2016-06-01 | Downgrade | Raymond James | Strong-Buy to Outperform | |
2016-06-01 | Downgrade | Raymond James Financial Inc. | Strong-Buy to Outperform | |
2016-05-05 | Boost Price Target | Wedbush | Outperform | $51.00 to $57.00 |
2016-05-05 | Upgrade | Piper Jaffray | Neutral to Overweight | $43.00 to $52.00 |
2016-05-05 | Boost Price Target | Roth Capital | Buy | $40.00 to $50.00 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In MASI 312 funds of 2213 total. Show all
Fund name | Ticker shares |
---|---|
BlackRock Inc. | 5.41M |
Vanguard Group, Inc | 4.63M |
FMR LLC | 3.86M |
BlackRock Fund Advisors | 3.42M |
BlackRock Institutional Trust Company, N.A. | 1.75M |
STATE STREET CORP | 1.66M |
RTW INVESTMENTS, LLC | 1.44M |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 1.21M |
Champlain Investment Partners, LLC | 0.93M |
GOLDMAN SACHS GROUP INC | 0.86M |
BLACKROCK ADVISORS LLC | 0.78M |
Fundsmith LLP | 0.77M |
MORGAN STANLEY | 0.70M |
GEODE CAPITAL MANAGEMENT, LLC | 0.67M |
CITIGROUP INC | 0.62M |
Name Relationship | Total Shares | Holding stocks |
---|---|---|
KIANI JOE E CEO and Chairman of the Board | 0.25% (139241) | MASI / SABA / STXS / |
CAHILL EDWARD L | 0.24% (129800) | MASI / TNDM / |
Lee Yongsam Chief Information Officer | 0.13% (71000) | MASI / |
Coleman Robert | 0.13% (70200) | MASI / |
Barker Steven | 0.12% (63249) | MASI / |
FITCH SANFORD | 0.11% (62249) | IRIX / MASI / |
Fishel Rick President Americas & OEM Bus | 0.04% (20022) | MASI / |
de Raad Mark EVP & Chief Financial Officer | 0.03% (14660) | MASI / |
Sampath Anand EVP, Engineering | 0.02% (12000) | MASI / |
Allan Anthony Chief Operating Officer | 0.02% (10524) | MASI / ZIGO / |
Coleman Jon President, International | 0.02% (9201) | MASI / |
Jansen Paul Executive VP, Marketing | 0.01% (6389) | MASI / |
Paul Stephen E. Vice President, US Acute Care | 0.01% (6000) | MASI / |
Harkin Thomas | 0.01% (3385) | MASI / |